amlodipine besylate and benazepril hydrochloride

FDA Drug Profile — Lotrel

Drug Details

Generic Name
amlodipine besylate and benazepril hydrochloride
Brand Names
Lotrel
Application Number
NDA020364
Sponsor
Novartis Pharmaceuticals Corporation
NDC Codes
4
Dosage Forms
CAPSULE
Routes
ORAL
Active Ingredients
AMLODIPINE BESYLATE, BENAZEPRIL HYDROCHLORIDE

Indications and Usage

1 INDICATIONS AND USAGE Amlodipine and benazepril hydrochloride capsule, is a combination capsule of amlodipine, a dihydropyridine calcium channel blocker (DHP CCB) and benazepril, an angiotensin converting-enzyme (ACE) inhibitor. Amlodipine and benazepril hydrochloride capsule, is indicated for the treatment of hypertension in patients not adequately controlled on monotherapy with either agent ( 1 ). 1.1 Hypertension Amlodipine and benazepril hydrochloride capsules are indicated for the treatment of hypertension in patients not adequately controlled on monotherapy with either agent.